BRD4 and pulmonary arterial hypertension: Recently, a preclinical study indicated that [69] inhibiting BRD4 by using JQ1 and siRNA could enhance pulmonary hemodynamics and alleviate vascular remodeling in sugen5416-hypoxia rats by reducing the apoptosis resistance and proliferation capacity of PAH-SMCs.